Literature DB >> 23575093

Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature.

Lutfiye Demir1, Alper Can, Rukiye Oztop, Ahmet Dirican, Vedat Bayoglu, Murat Akyol, Yuksel Kucukzeybek, Cigdem Erten, Isil Somali, Mustafa Oktay Tarhan.   

Abstract

Epithelioid hemangioendothelioma is a rare, low-grade malignant vascular tumour. It is frequently seen in the liver, but can occur in the lungs, bones, and other soft tissues. Although survival time might be reasonable in cases that can undergo liver transplantation, there is no consensus on the treatment of metastatic patients. We report a 24-year-old female patient with rapidly progressing malignant epithelioid hemangioendothelioma that presented with acute abdominal distension. The patient was refractory to anthracycline and Interferon treatment and died 6.5 months after the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575093     DOI: 10.4103/0973-1482.110386

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

Review 1.  Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.

Authors:  Valeriya Semenisty; Inna Naroditsky; Zohar Keidar; Gil Bar-Sela
Journal:  BMC Cancer       Date:  2015-05-13       Impact factor: 4.430

2.  Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?

Authors:  Anastasios Kyriazoglou; Konstantinos Koutsoukos; Flora Zagouri; Michalis Liontos; Efthimios Dimitriadis; Dina Tiniakos; Meletios Athanasios Dimopoulos
Journal:  Ther Clin Risk Manag       Date:  2020-02-27       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.